ArticleFrontiers in oncology2026
A phase II randomized controlled trial of orally administered yeast-derived β-glucan for alleviating chemoradiotherapy-induced oral mucositis in nasopharyngeal carcinoma patients.
Xiwei Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.